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The aim of this study was to determine whether there is an association 
between leukocyte telomere length (LTL), and estrogen level, oxidative 
stress, cardiovascular disease (CVD) risk factors, and cardiorespiratory 
fitness (CRF) in pre- and postmenopausal obese women. Fifty-four 
obese women (premenopausal, n= 25; postmenopausal, n= 29) were 
selected to participate in this study. The outcome measurements in the 
pre- and postmenopausal groups were compared using independent 
t-tests and Pearson correlation analysis. The estrogen level (P< 0.001), 
LTL (P< 0.05), high-density lipoprotein level (P< 0.05), and CRF (P< 0.001) 
were higher in premenopausal women than in postmenopausal wom-
en. The body fat percentage (P< 0.05) and triglyceride concentration 
(P< 0.05) were lower in premenopausal women than in postmenopaus-
al women. There were no significant associations between LTL, CVD 
risk, CRF, and oxidative stress and antioxidant enzyme activity in pre-
menopausal women. The body mass index (BMI) and body fat percent-
age in postmenopausal women were negatively associated with LTL 
(P< 0.05). When all women were considered (i.e., both pre- and post-
menopause), the BMI, percentage of fat, and waist circumference had 
a negative association with LTL (P< 0.05), and estrogen levels were 
positively associated with LTL (P< 0.05). Decreased estrogen levels af-
ter menopause, a pivotal factor in the biology of aging, and obesity were 
more associated with shorter telomere lengths in pre- and postmeno-
pausal women than aerobic capacity and other CVD risk factors. 
Keywords: Telomere, Menopause, Obesity, Estrogen, Cardiovascular 
disease risk factors
INTRODUCTION
Telomeres are tandem repeats of hexanucleotide sequences 
(TTAGGG) that are associated with specialized DNA-protein 
complexes located at both ends of eukaryotic chromosomes 
(Blackburn, 1991). Telomeres are essential for stabilization and 
protection of chromosomal ends from recombination, fusion, and 
degradation, and for the regulation of cell replicative capacity 
(Hodes, 1999). When cells divide, the telomere is not fully repli-
cated because of limitations in the DNA polymerases in complet-
ing the replication of the ends of the linear molecules, leading to a 
telomere attrition of 50–200 bp in various human cells (Lansdorp, 
2005). 
The importance of telomeres in vascular pathobiology has pre-
viously been identified. Recently, there has been a special empha-
sis on insights into the mechanisms that alter telomere homeosta-
sis in response to several atherogenic stimuli and conditions, in-
cluding estrogen levels, oxidative stress, hypertension, and diabe-
tes. A shorter telomere has been associated with increased risks of 
cardiovascular disease (CVD) (Aviv, 2002; Edo and Andrés, 2005; 
Fitzpatrick et al., 2007). CVD risk factors such as insulin resis-
tance, hypertension, and obesity, are associated with up-regulated 
oxidant stress (Maytin et al., 1999) and shortened telomeres (Na-
kashima et al., 2004). 
Although CVD caused by atherosclerosis is rare in premeno-
pausal women, the incidence of CVD increases after menopause 
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(Pitha et al., 2013). Menopause and the rapid changes during the 
menopausal transition could be important in changing CVD risk 
factors and atherosclerosis development (Woodard et al., 2011; 
Zaydun et al., 2006). Lejsková et al. (2011) detected a high preva-
lence of metabolic CVD risk factors in women before and after 
menopause (aged 45–54 yr). In addition, they found that the 
menopausal status was a risk factor for the development of hyper-
tension, which is thought to be potentially mediated through an 
increased body mass index (BMI) (Cifkova et al., 2008). Increase 
estrogen levels have also been shown to reduce oxidative stress 
(Song et al., 2009; Wong et al., 2008) and therefore, may indi-
rectly affect telomere maintenance. However, the in vivo relation-
ship between estrogen and telomere length is not well under-
stood. Determining these relationships would be beneficial to un-
derstanding the possible mechanisms by which estrogens influ-
ence both CVD and oxidative stress. 
Regular physical activity has been known to be an important 
factor in the prevention and treatment of CVD. Furthermore, 
physically active individuals are known to have reduced morbidi-
ty and mortality associated with health and CVD compared to 
sedentary controls (Kojda and Hambrecht, 2005). According 
many studies, regular exercise up-regulates the antioxidant system 
(McArdle and Jackson, 2000) and stimulates the repair system 
against oxidative damage (Radák et al., 1999; Sato et al., 2003). 
Moreover, regular aerobic exercise and high aerobic capacity are 
associated with a better maintenance of cellular functions during 
aging compared to sedentary lifestyles (LaRocca et al., 2010). 
Despite these previous findings, the association between telo-
mere length and physical activity is not unequivocal. Increasing 
physical activity has been shown to have a positive correlation 
with telomere length (Cherkas et al., 2008; Zhu et al., 2011), but 
the linear association has not been confirmed in all studies (Collins 
et al., 2003; Ludlow et al., 2008). Furthermore, no association be-
tween physical activity and telomere length was found in one pre-
vious study (Cassidy et al., 2010). Recently, LaRocca et al. (2010) 
reported that the leukocyte telomere length (LTL) in older endur-
ance-trained adults was approximately 900 bp greater than that in 
their sedentary peers, and LTL has a significant positive association 
with VO2max. However, telomere length was shown to be influ-
enced by sex because vigorous physical activity in adolescents was 
positively associated with telomere length in only females (Zhu et 
al., 2011). Longer LTLs were consistently observed in women 
compared with men (Aviv et al., 2005), which have been ascribed 
to the ability of estrogen to up-regulate telomerase and concur-
rently reduce oxidative stress (Calado, 2009; Song et al., 2009). 
It is believed that decreased estrogen levels in women is the 
main cause of an increased CVD risk prevalence along with in-
creased central adiposity (Poehlman et al., 1995; Toth et al., 2000) 
and an unfavorable lipid profile after menopause (Agrinier et al., 
2010; Kuh et al., 2005). Regular exercise helps relieve stress, en-
hances overall quality of life, and reduces weight gain and muscle 
loss, which are the most frequent side effects of menopause (Sto-
janovska et al., 2015). Furthermore, it has been previously shown 
that moderate to high level of cardiorespiratory fitness (CRF) due 
to regular exercise decreased the risk of developing CVD in adults 
(Blair et al., 1996). However, CRF has not yet been fully exam-
ined in a well-characterized population of healthy sedentary and 
obese pre- and postmenopausal women. Information regarding 
the telomere length and CRF in pre- and postmenopausal women 
is also limited. 
Based on these previous findings, obese menopausal women 
may induce oxidative stress, which can cause the development of 
CVD. Furthermore, a higher CRF due to regular exercise can 
down-regulate the obesity condition, oxidative stress, and CVD 
risk factors, which might be a unifying mechanism in decreased 
telomere shortening. Therefore, we examined whether there is an 
association between LTL and estrogen level, oxidative stress, CVD 
risk factors, and CRF in pre- and postmenopausal obese women. 
MATERIALS AND METHODS 
Subjects and experiment design
Fifty-four obese Korea middle-aged women participated in this 
study. Women who were included in the study had the following 
criteria: not suffering from metabolic disorders, nonsmokers, not 
taking anti-inflammatory drugs or steroids, not undergoing hor-
mone replacement therapy, had not undergone surgery within the 
previous 3 months, and a BMI of ≥25 kg/m2. Informed consent 
was obtained from all subjects prior to their participation in this 
study. The study subjects completed questionnaires regarding 
their medical and exercise history, which included questions per-
taining to diseases, age at menopause, alcohol consumption, ciga-
rette smoking, use of anti-inflammatory drugs or steroids, surgical 
history, duration of exercise, type of exercise, and regular exercise 
participation within the previous 3 months. The present study 
was approved by the Institutional Ethnics Committee of Physical 
Education of Dankook University. 
Physical examination
Anthropometric measurements were performed by trained and 
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certified observers. The height, body weight, and body fat per-
centage of the study participants were recorded (INBODY 3.0, 
Biospace, Seoul, Korea) and BMI was calculated as weight (kg)/
height (m2). Obesity was defined as a BMI ≥25 kg/m2 according 
to the Korea Society for the Study of Obesity (Korean Society for 
the Study of Obesity, 2013). Waist circumference (WC) was de-
termined at the level of the natural waist, between the ribs and 
the iliac crest, at the end of a normal expiration. Blood pressure 
was measured in duplicate (after a 5-min rest interval), on the 
right arm with the subjects in a sitting position by qualified phy-
sicians or nurses using a standard mercury sphygmomanometer. 
Hypertension was defined as a systolic blood pressure (SBP) of 
≥140 mmHg and a diastolic blood pressure (DBP) of ≥90 
mmHg.
Blood collection and assessment of biomarkers
Venous blood samples were obtained from the participants after 
an overnight fast to measure lipid and glucose levels and avoiding 
the menstrual cycle to measure estrogen. Blood serum aliquots 
were stored at -80˚C until assayed. Triglyceride (TG) and high- 
density lipoprotein cholesterol (HDL-C) levels were measured us-
ing the enzymatic colorimetric method and analyzed using the 
COBAS integra 800 (Roche, Basel, Switzerland). Plasma glucose 
levels were measured with a commercially available glucose hex-
okinase kit (ADVIA 1650, Bayer, Tokyo, Japan). Dyslipidemia 
was defined as a TG level ≥150 mg/dL and HDL-C level <40 
mg/dL. Estrogen was assayed by electrochemiluminescence im-
munoassay using Elecasys 2010 (Roche, Indianapolis, IN, USA). 
CRF testing
The VO2max of each subject was measured to objectively mea-
sure CRF. Subjects were familiarized with treadmill running and 
were informed of their requirements during the experiment. Af-
terwards, the participants completed a graded treadmill exercise 
test to determine their individual VO2max according to the Bruce 
Protocol. Metabolic data were collected using open circuit spi-
rometry (Vmax29, Sensormedics, Yorba Linda, CA, USA).
Analysis of oxidative stress and antioxidant enzyme 
activity
For both experiments, serum aliquots were stored at -80˚C until 
assayed. A total of 10 mL of blood was obtained from the subjects 
before and after exercise testing and overnight fasting. A Diode 
spectrophotometer (HP8452A, SpectraLab Scienctific Inc., Toron-
to, Canada) was used to assess the malondialdehyde (MDA) levels 
in the serum, according to the manufacturer’s instructions. Butyl-
ated hydroxyl toluene and chromogenic reagent were added to 
samples and warmed to 45˚C for 60 min. Absorbance values were 
obtained spectrophotometrically at 586 nm. The MDA levels 
were reported as μmol serum. The erythrocyte superoxide dis-
mutase (SOD) and glutathione peroxidase (GPX) activities were 
assessed by the enzyme-linked immunosorbent assay method us-
ing commercially available kits (IBL, Hamburg, Germany). 
Analysis of mean telomere length in leukocyte 
DNA samples, extracted from leukocyte, were digested with 
restriction enzymes Hinf and Risa (1 μg each; Roche, Mannheim, 
Germany). Sixteen DNA samples (17 μg each), high and low 
DNA control (17 μg each), and 2 DNA ladders (l kb) were re-
solved on a 0.8% agarose gel (20 cm×20 cm) at 100 V in 
1×TAE buffer. After 8 hr, the DNA was depurinated for approxi-
mately 5–10 min in 0.25 bM HCl solution until the bromophe-
nol blue stain changed its color to yellow, denatured for 15 min 
×2 in 0.5-M NaOH, 1.5-M NaCl, and neutralized for 15 min 
×2 in 0.5-M Tris, 3-M NaCl, pH 7.5. The DNA was transferred 
overnight to a positively charged nylon membrane using 20×sa-
line-sodium citrate (SSC). After Southern blot transfer, the trans-
ferred DNA was fixed on the wet blotting membrane by ultravio-
let-crosslinking (120 mJ) and membranes were baked at 65˚C for 
4 hr. The membranes were prehybridized at 42˚C with prewarmed 
DIG Easy Hyb for 4 hr (Roche, Mannheim, Germany) and hy-
bridized overnight at 42˚C with prewarmed DIG Easy Hyb and a 
1-μL telomere probe (Roche, Mannheim, Germany). The mem-
branes were washed twice with 2×SSC for 5 min and twice with 
0.2×SSC for 20 min at 50˚C. After the membranes were washed, 
telomeric DNA was detected by the chemiluminescence detection 
procedure (Roche, Mannheim, Germany) and exposed on a radio-
graph. 
Statistical analysis
All data were represented as mean±standard deviation. Differ-
ences in the physical characteristics, CVD risk, CFR, and oxida-
tive stress and antioxidant enzyme activity between pre- and post-
menopausal women were evaluated using independent t-test. As-
sociations between LTL, CVD risk, CRF, and oxidative stress and 
antioxidant enzyme activity were analyzed using Person correla-
tion analysis. All statistical analyses were performed using the 
SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA) and P-values <0.05 
were considered statistically significant.
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RESULTS
Physical characteristics of subjects according to the 
menopause state
The physical characteristics of pre- and postmenopausal women 
are shown in Table 1. Age (P<0.001) was lower in premenopausal 
women compared to postmenopausal women. Height (P<0.05), 
estrogen level (P<0.001), and LTL (P<0.05) were higher in pre-
menopausal women compared to postmenopausal women.
CVD risk factors and CRF of subjects according to the 
menopause state
The CVD risk and CRF of pre- and postmenopausal women are 
shown in Table 2. The percentage of body fat (P<0.05) and TG 
concentration (P<0.05) were lower in premenopause women 
compared to postmenopausal women. However, HDL-C level 
(P<0.05) and CRF (P<0.001) were higher in premenopausal 
women than those who were postmenopausal.
Oxidative stress and antioxidant enzyme activity of 
subjects according to the menopause state
The oxidative stress and antioxidant levels of pre- and post-
menopausal women are shown in Table 3. There were no signifi-
cant differences in the MDA, SOD, and GPX levels between the 
pre- and postmenopausal groups.
Associations between LTL and CVD risk, CRF, and oxidative 
stress and antioxidant enzyme activity 
In premenopausal women, there were no significant associations 
among LTL, CVD risk, CRF, and oxidative stress and antioxidant 
enzyme activity (Table 4). In postmenopausal women, BMI and 
the body fat percentage were shown to have a negative association 
with LTL (P<0.05). In total (i.e., both pre- and postmenopausal 
women), the BMI, body fat percentage, and WC were shown to 
Table 1. The physical characteristics of subjects according to the menopause 
state   
Variable Premenopause (n= 25) Postmenopause (n= 29) Sig
Age (yr) 46.08± 5.27 57.22± 2.52 < 0.001***
Height (cm) 157.55± 3.84 154.81± 4.56 0.021*
Weight (kg) 64.47± 7.43 64.37± 9.69 0.967
Estrogen (pg/mL) 654.61± 263.55 296.53± 187.79 < 0.001***
LTL (kp) 8.29± 1.97 7.13± 1.89 0.031*
Values are presented as mean± standard deviation.    
LTL, leukocyte telomere length.   
*P< 0.05. ***P< 0.001.   
Table 2. Cardiovascular risk factors and cardiorespiratory fitness according to 
the menopause state   
Variable Premenopause (n= 25)
Postmenopause 
(n= 29) Sig
Body mass index (kg/m2) 25.91± 2.20 26.83± 3.72 0.285
Body fat (%) 31.03± 4.47 33.71± 4.20 0.025*
Waist circumference (cm) 82.77± 7.60 83.57± 6.91 0.727
SBP (mmHg) 121.65± 11.16 126.50± 12.05 0.135
DBP (mmHg) 81.77± 10.75 86.80± 9.89 0.101
FBG (mg/dL) 88.56± 7.02 92.28± 9.04 0.095
HDL-C (mg/dL) 53.08± 16.96 44.38± 9.66 0.018*
Triglyceride (mg/dL) 113.14± 51.72 177.47± 102.77 0.010*
VO2max (mL/kg/min) 33.15± 3.66 27.69± 5.29 < 0.001***
Values are presented as mean± standard deviation.    
SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glu-
cose; HDL-C, high-density lipoprotein cholesterol.   
*P< 0.05. ***P< 0.001.  
Table 3. Oxidative stress and antioxidant levels of subjects according to their 
state of menopause   
Variable Premenopause (n= 25) Postmenopause (n= 29) Sig
MDA (μmol) 1.39± 0.75 1.69± 0.85 0.203
SOD (U/m) 1.34± 0.71 1.26± 0.59 0.677
GPx (nmol/min/mL) 152.05± 29.61 152.36± 24.53 0.969
Values are presented as mean± standard deviation.    
MDA, malondialdehyde; SOD, superoxide dismutase; GPx, glutathione peroxidase.
Table 4. The association between mean leukocyte telomere length and car-
diovascular risk factors, cardiorespiratory fitness, and oxidative stress and an-









Body mass index (kg/m2) -0.035 -0.391* -0.293*
Body fat (%) 0.019 -0.408* -0.272*
Waist circumference (cm) -0.247 -0.288 -0.310*
SBP (mmHg) 0.020 0.057 -0.025
DBP (mmHg) -0.059 -0.080 -0.133
FBG (mg/dL) -0.320 0.042 -0.162
HDL-C (mg/dL) 0.297 -0.336 0.129
Triglyceride (mg/dL) -0.240 0.196 -0.052
VO2max (mL/kg/min) -0.087 -0.210 0.031
MDA (μmol) -0.077 0.071 -0.021
SOD (U/m) -0.072 -0.153 -0.094
GPx (nmol/min/mL) -0.290 0.159 -0.032
Estrogen (pg/mL) 0.376 0.018 0.286*
SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glu-
cose; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; MDA, malondial-
dehyde; SOD, superoxide dismutase; GPx, glutathione peroxidase.  
*P< 0.05.    
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have a negative association with LTL (P<0.05), but estrogen level 
was shown to have a positive association with LTL (P<0.05).
DISCUSSION
The main findings of this study were as follows: (a) LTL was 
different between pre- and postmenopausal women, (b) estrogen 
level was associated with telomere attrition, and (c) increased BMI 
and body fat percentage contributed to accelerated telomere attri-
tion, especially in postmenopausal women. The role of estrogen in 
modifying vascular disease risk in women is contentious. Meno-
pause is associated with increased risk for ischemic heart disease 
and cerebrovascular disease, which are the collective main causes 
of morbidity and mortality in women of developed nations (Lin et 
al., 2011). 
Estrogen level and LTL were significantly different between 
pre- and postmenopausal women in this study. In previous stud-
ies, it has been reported that estrogen increases telomerase activity 
(Kyo et al., 1999) and higher estrogen levels have antioxidant ef-
fects via several mechanisms, such as scavenging free radicals, in-
hibiting free radical production, and stimulating some enzymes 
involved in detoxification (Massafra et al., 2000; Römer et al., 
1997; Sack et al., 1994). However, we did not find any difference 
in the oxidative stress and antioxidants levels and estrogen levels 
in pre- and postmenopausal women. Moreover, estrogen levels 
were observed to have a positive association with LTL. According 
to these result, estrogens affect the LTL and may have contributed 
to the observed difference in LTL between in pre- and postmeno-
pausal women regardless of their oxidative stress and antioxidant 
enzyme activities. 
No significant differences in SBP, DBP, and fasting blood glu-
cose levels were observed between pre- and postmenopausal wom-
en in our study, which was similar to the studies conducted by 
Chang et al. (2000) and He et al. (2012). Furthermore, these risk 
factors were not shown to be related to LTL. A high prevalence of 
dyslipidemia and high blood lipid levels were associated with 
menopause in this study, and these results were consistent with 
other findings from Western countries and China (Agrinier et al., 
2010; Feng et al., 2008; Kuh et al., 2005). Changes in the lipid 
profile were observed to occur as early as the perimenopause peri-
od in several studies (Agrinier et al., 2010; Fukami et al., 1995), 
which could be related to decreased estrogen levels during meno-
pause (Everson et al., 1991; Walsh et al., 1991). 
The telomere length was not correlated with CVD risk in our 
study despite a higher TG and lower HDL-C levels in women 
who were postmenopausal compared to those who were premeno-
pausal. It was reported that HDL-C levels were independently 
and positively associated with LTL during childhood and adult-
hood in a previous study (Chen et al., 2009) and in cross-sectional 
study conducted in high-risk populations (Adaikalakoteswari et 
al., 2007). A putative explanation for this association is that 
HDL-C has antioxidant and anti-inflammatory properties, and 
LTL ostensibly reflects the cumulative burden of inflammation 
and oxidative stress (Nofer et al., 2005). Low HDL-C level pheno-
types have been shown to display elevated oxidative stress and ac-
celerated senescence, which suggests that a reduced LTL could be 
a biomarker of increased oxidative stress and inflammation (Kon-
tush et al., 2005). We were unable to determine whether inflam-
mation, oxidative stress, CVD risk, or their combination contrib-
utes to accelerated telomere attrition that accompanies menopause 
in this study. However, the MDA level of the subjects was approx-
imately 0.45–3.92 µmol, which is not a high stress condition. 
Epel et al. (2004) reported that a person with low oxidative stress 
has a longer telomere length compared to a person in a high oxi-
dative stress condition. The telomere length did not correlate with 
CVD risk in this study because the participants were not severely 
obese.
Regular physical activity reduces the risk for obesity, type 2 di-
abetes, hypertension, and cancer in adults. Furthermore, physical 
activity is positively associated with LTL in adults, which suggests 
an antiaging property (Cherkas et al., 2008; LaRocca et al., 2010; 
Ludlow et al., 2008; Ponsot et al., 2008). Physical activity during 
leisure time was correlated with a longer telomere length in the 
United Kingdom Adult Twin Registry (Ludlow et al., 2008). 
Puterman et al. (2010) found that the relationship between stress 
and short telomeres was attenuated in women who exercised the 
amount recommended by the Center for Disease Control and Pre-
vention (an average of 75 min of vigorous activity/week). Howev-
er, Savela et al. (2013) reported that long-term moderate physical 
activity levels during leisure time were associated with longer 
mean LTLs compared to both low and high physical activity lev-
els. In a study of 69 volunteers aged 50–70 yr, Ludlow et al. 
(2008) also reported that moderate physical activity levels were 
associated with longer LTLs compared to both the lowest and the 
highest quartiles of physical activity. Furthermore, Collins et al. 
(2003) supported these findings of endurance athletes by indicat-
ing that participants with fatigued athlete myopathic syndrome 
had a severe reduction in skeletal muscle DNA telomere length 
compared to 13 healthy athletes. 
CRF, estrogen levels, and LTL were shown to be significantly 
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different between pre- and postmenopausal women in this study; 
however, CRF was not associated with LTL. The various mecha-
nisms by which exercise may affect aging at the cellular level are 
currently not fully understood; however, lower basal levels of reac-
tive oxygen species in mitochondria, increased activity of antioxi-
dants and damage repair enzymes (Baar, 2004; Radak et al., 
2008), and up-regulation of neurotropic factors (Dishman et al., 
2006) have been proposed to be involved. Telomere length has 
been considered a possible link between physical activity and 
health (Ludlow and Roth, 2011). However, LaRocca et al. (2010) 
reported that LTL is not influenced by aerobic exercise among 
young subjects (18–32 yr); however, LTL was related to regular 
vigorous aerobic exercise and maximal aerobic exercise capacity in 
aged healthy humans. These results were due to modulations of 
VO2max by habitual aerobic exercise; however, up to ~50% of 
VO2max is determined primarily by genetic factors (Bouchard et 
al., 1998). The subjects of this study were obese women, which 
may have affected the telomere length more than VO2max regard-
less of their menopause state. 
Menopause leads to changes in metabolic functions in women, 
which may act as risk factors for CVD. Therefore, the menopause 
state has been considered as another, but unique, CVD risk factor 
for women in addition to aging. In Rosamond et al. (2007), CVD 
risk increased rapidly and to a greater degree in menopausal wom-
en than men. Gordon et al. (1978) noted an increase in the inci-
dence of coronary heart disease after menopause in a cohort of 
Framingham women. Furthermore, in a population study in the 
Netherlands, Witteman et al. (1989) observed that women hav-
ing natural menopause had a 3 times greater risk of atherosclerosis 
than premenopausal women. 
According to the results of this study, body compositions were 
not significantly different between the pre- and postmenopausal 
groups, except for body fat percentage because all subjects were in 
an obese condition. However, LTL was negatively associated with 
BMI, WC, and body fat percentage in the total study population 
(i.e., both pre- and postmenopausal women). Recently, Lee et al. 
(2011) reported that BMI, WC, hip circumference, total body fat, 
and visceral adipose tissue volume were all inversely associated 
with telomere length. Telomere lengths measured from subcuta-
neous adipocytes of obese patients were significantly lower than 
patients who were never obese (Moreno-Navarrete et al., 2010). 
Obesity is associated with increased inflammation because fat tis-
sues are a major source of inflammatory cytokines (Keaney et al., 
2003). Inflammation is a source of oxidative stress (Festa et al., 
2001), which plays a critical role in the pathogenesis of various 
diseases (Brownlee, 2001). Inflammation also promotes increased 
leukocyte turnover, which would enhance telomere attrition 
(Gardner et al., 2007). In addition, increased adiposity is accom-
panied by angiogenesis to accommodate the growing metabolic 
needs of the expanding fat mass (Rupnick et al., 2002), which ex-
plains the increased central and total blood volume of obese sub-
jects (Oren et al., 1996). Therefore, obese individuals may need to 
increase the total number of circulating leukocytes to maintain 
the peripheral leukocyte pool. Although the body fat percentage 
was different between the pre- and postmenopause groups, the 
subjects included in this study were all obese. BMI and body fat 
percentage were negatively associated with LTL in postmenopause 
women. Therefore, the obese condition contributed to accelerated 
telomere attrition, which accompanies body fat gain especially in 
postmenopause conditions. 
In conclusion, a decreased estrogen level after menopause is re-
lated to dyslipidemia (i.e., higher TG and lower HDL-C levels) 
and a shorter telomere length compared to premenopause. VO2m-
ax did not affect the LTL; however, we observed that obesity con-
ditions (i.e., BMI, body fat, WC, and estrogen levels) were associ-
ated with LTL in the total study population. BMI and body fat 
percent were especially related to LTL in postmenopausal women. 
Decreased estrogen levels after menopause is considered a pivotal 
factor in aging, and both low estrogen levels and obesity condi-
tions were more associated with shorter telomere lengths in pre- 
and postmenopause women than aerobic capacity and other CVD 
risk factors. Therefore, obesity should be treated with an emphasis 
on LTL especially in postmenopausal women because of their ag-
ing process. 
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